I'm stuck in the gray market for GLP-1s
US$ 26.06
glp 1 gip triple agonist GLP-1 / / Glucagon Receptor (CAS 2381089-83-2) The Road towards Triple Agonists:
Description
and GSBR-1290, now in early Phase IIa evaluation
doi:10.1042/bsr20241510 Li Z, Wu J, Song J, Wen Y
While these medications can be beneficial for some, they can also come with unpleasant side effects like nausea, constipation and fatigue
It is also not recommended for patients with existing gastrointestinal disease to avoid potential side effects or exacerbating the condition
